These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31241381)

  • 1. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
    Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
    Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
    [No Abstract]   [Full Text] [Related]  

  • 2. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
    Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
    Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.
    Hawkins PG; Lee JY; Mao Y; Li P; Green M; Worden FP; Swiecicki PL; Mierzwa ML; Spector ME; Schipper MJ; Eisbruch A
    Radiother Oncol; 2018 Jan; 126(1):68-74. PubMed ID: 28823405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma.
    Schanne DH; Alder DU; Lippmann J; Aebersold DM; Elicin O
    Radiat Oncol; 2024 Aug; 19(1):104. PubMed ID: 39095864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
    de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
    Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized phase III trial for alleviating radiation-induced xerostomia with chewing gum.
    Kaae JK; Stenfeldt L; Hyrup B; Brink C; Eriksen JG
    Radiother Oncol; 2020 Jan; 142():72-78. PubMed ID: 31606226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
    Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
    World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
    Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
    Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
    Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
    Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.
    Henson BS; Inglehart MR; Eisbruch A; Ship JA
    Oral Oncol; 2001 Jan; 37(1):84-93. PubMed ID: 11120488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
    Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
    Radiother Oncol; 2007 Oct; 85(1):83-9. PubMed ID: 17391790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.